Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 19204129)

1.

Prescribing discrepancies likely to cause adverse drug events after patient transfer.

Boockvar KS, Liu S, Goldstein N, Nebeker J, Siu A, Fried T.

Qual Saf Health Care. 2009 Feb;18(1):32-6. doi: 10.1136/qshc.2007.025957.

2.

Reply to discrepancies in drug approvals: A global dilemma.

Ezeife DA, Truong TH, Tang PA.

Cancer. 2015 Jun 16. doi: 10.1002/cncr.29482. [Epub ahead of print] No abstract available.

PMID:
26080025
3.

Discrepancies in drug approvals: A global dilemma.

Wilson MK, Karakasis K, Oza AM.

Cancer. 2015 Jun 16. doi: 10.1002/cncr.29484. [Epub ahead of print] No abstract available.

PMID:
26079099
4.

Impact of a Swiss adverse drug event prevention collaborative.

Staines A, Mattia C, Schaad N, Lécureux E, Bonnabry P.

J Eval Clin Pract. 2015 May 26. doi: 10.1111/jep.12376. [Epub ahead of print]

PMID:
26011777
5.

Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.

Overhage JM, Gandhi TK, Hope C, Seger AC, Murray MD, Orav EJ, Bates DW.

J Patient Saf. 2015 May 21. [Epub ahead of print]

PMID:
26001546
6.

Analyzing performance discrepancies-part 2.

Modic MB.

J Nurses Prof Dev. 2015 May-Jun;31(3):180-1. doi: 10.1097/NND.0000000000000181. No abstract available.

PMID:
25993459
7.

Assessing the potential adoption and usefulness of concurrent, action-oriented, electronic adverse drug event triggers designed for the outpatient setting.

Mull HJ, Rosen AK, Shimada SL, Rivard PE, Nordberg B, Long B, Hoffman JM, Leecaster M, Savitz LA, Shanahan CW, Helwig A, Nebeker JR.

EGEMS (Wash DC). 2015 Apr 30;3(1):1116. doi: 10.13063/2327-9214.1116. eCollection 2015.

8.

Meaningful Use Stage 2 E-Prescribing Threshold and Adverse Drug Events in the Medicare Part D Population with Diabetes.

Powers C, Gabriel MH, Encinosa W, Mostashari F, Bynum J.

J Am Med Inform Assoc. 2015 May 6. pii: ocv036. doi: 10.1093/jamia/ocv036. [Epub ahead of print]

PMID:
25948698
9.

Analyzing performance discrepancies.

[No authors listed]

J Nurses Prof Dev. 2015 Mar-Apr;31(2):120-1. doi: 10.1097/NND.0000000000000155. No abstract available.

PMID:
25790366
10.

A formal medication reconciliation programme in a haemodialysis unit can identify medication discrepancies and potentially prevent adverse drug events.

Chan WW, Mahalingam G, Richardson RM, Fernandes OA, Battistella M.

J Ren Care. 2015 Jun;41(2):104-9. doi: 10.1111/jorc.12107. Epub 2015 Feb 19.

PMID:
25703922
11.

Quick assessment of drug-related admissions over time (QUADRAT study).

Warlé-van Herwaarden MF, Valkhoff VE, Herings RM, Engelkes M, van Blijderveen JC, Rodenburg EM, de Bie S, Alsma J, van de Steeg-Gompel C, Kramers C, Meyboom RH, Sturkenboom MC, De Smet PA.

Pharmacoepidemiol Drug Saf. 2015 May;24(5):495-503. doi: 10.1002/pds.3747. Epub 2015 Feb 12.

PMID:
25683383
12.

Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.

Call RJ, Burlison JD, Robertson JJ, Scott JR, Baker DK, Rossi MG, Howard SC, Hoffman JM.

J Pediatr. 2014 Sep;165(3):447-52.e4. doi: 10.1016/j.jpeds.2014.03.033. Epub 2014 Apr 25.

PMID:
24768254
13.

Hospital admissions caused by adverse drug events: an Australian prospective study.

Phillips AL, Nigro O, Macolino KA, Scarborough KC, Doecke CJ, Angley MT, Shakib S.

Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027.

PMID:
24351707
14.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
15.

Incidence of adverse drug events in an academic hospital: a prospective cohort study.

Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD, Bates DW.

Int J Qual Health Care. 2013 Dec;25(6):648-55. doi: 10.1093/intqhc/mzt075. Epub 2013 Oct 17.

16.

Use and perceived benefits of mobile devices by physicians in preventing adverse drug events in the nursing home.

Handler SM, Boyce RD, Ligons FM, Perera S, Nace DA, Hochheiser H.

J Am Med Dir Assoc. 2013 Dec;14(12):906-10. doi: 10.1016/j.jamda.2013.08.014. Epub 2013 Oct 2.

17.

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.

Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, Asscheman H, de Rooij SE, Lie-A-Huen L, Smorenburg SM; WINGS Study Group.

PLoS One. 2013 Aug 5;8(8):e71045. doi: 10.1371/journal.pone.0071045. Print 2013.

18.

Loving and lamenting the role of medications in long term care.

Sloane PD, Burkhart JI.

J Am Med Dir Assoc. 2013 Jun;14(6):384-5. doi: 10.1016/j.jamda.2013.03.023. No abstract available.

PMID:
23764208
19.

Adverse drug events in surgical patients: an observational multicentre study.

de Boer M, Boeker EB, Ramrattan MA, Kiewiet JJ, Dijkgraaf MG, Boermeester MA, Lie-A-Huen L.

Int J Clin Pharm. 2013 Oct;35(5):744-52. doi: 10.1007/s11096-013-9797-5. Epub 2013 May 31.

PMID:
23722455
20.

Profile of prescribing errors detected by clinical pharmacists in paediatric hospitals in Spain.

Fernández-Llamazares CM, Pozas M, Feal B, Cabañas MJ, Villaronga M, Hernández-Gago Y, Ruiz de Villegas M, Álvarez-del-Vayo C.

Int J Clin Pharm. 2013 Aug;35(4):638-46. doi: 10.1007/s11096-013-9785-9. Epub 2013 May 25.

PMID:
23708882
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk